Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms and make Nvidia’s BioNeMo tools available on the next-gen sequencing giant’s Illumina Connected ...

Illumina's leading sequencing technology, as well as its menu of DRAGEN-powered multiomics offerings, genomics AI tools and Illumina Connected Analytics platform, has streamlined genomic data ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that ...

During the first phase of this collaboration, Illumina is working to integrate its existing DRAGEN algorithms to mesh with Nvidia’s processors. “AI and data science will find their most profou ...

Illumina's leading sequencing technology—as well as its menu of DRAGEN-powered multiomics offerings, genomics AI tools, and Illumina Connected Analytics platform—has streamlined genomic data ...

圣地亚哥 - 年收入43.9亿美元的基因组测序领军企业Illumina公司（纳斯达克股票代码：ILMN）宣布与科技巨头英伟达合作，以增强多组学数据的分析和解读，此举有望加速临床研究和药物发现。根据 InvestingPro 数据，该公司保持67.61%的健康毛利率，并维持适度的债务水平。这项合作将整合Illumina的测序技术和信息学工具与英伟达的人工智能（AI）能力。

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing giant’s Illumina Connected Analytics (ICA) platform. By integrating ...

Illumina's leading sequencing technology—as well as its menu of DRAGEN-powered multiomics offerings, genomics AI tools, and Illumina Connected Analytics platform—has streamlined genomic data ...